Sign in

CIK 0001660334

  • Non-accelerated filer
  • Smaller reporting company

Verrica Pharmaceuticals Inc.

Sign in to watch
Ticker
VRCA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
463137900
Phone
+1 484-453-3300
Business address
44 WEST GAY STREET, SUITE 400, WEST CHESTER, PA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-08-17 Zawitz David Chief Operating Officer Purchase +6,000 $4.98 $30K 27,000
2026-06-05 Zawitz David Chief Operating Officer Grant or award · Employee Stock Option (right to buy) +171,340 171,340
2025-11-25 Zawitz David Chief Operating Officer Purchase +10,000 $4.24 $42K 21,000
2025-11-25 Zawitz David Chief Operating Officer Purchase · Series C Warrant (right to buy) +2,500 2,500
2024-12-09 Zawitz David Chief Operating Officer Grant or award · Employee Stock Option (right to buy) +950,000 950,000

Page 1 of 1 · 5 trades